rs688

Variant summary

Our verdict is Benign.
-8 Benign
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received -8 classification points (ACGS-UK Somatic Oncogenicity v2025). B1_StrongB4_Strong

The NM_000527.5(LDLR):c.1773C>T (p.Asn591Asn) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The gene LDLR is a known oncogene (CancerMine: 2 oncogene citations). The variant allele was found at a cumulative frequency of 0.417 (AC=673,211) in the gnomAD database across 1,613,584 control chromosomes, including 147,093 homozygotes. The grpmax filtering allele frequency (95% CI) is 0.446. In-silico predictor (BayesDel (noAF)) classifies this variant as likely benign. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign/Likely Benign (★★). The variant has been observed in cBioPortal in 1 sample across 1 study and 1 cancer type; somatic enrichment level: NONE (Observed in at most one deduplicated cBioPortal case.).

Frequency

Genomes: 𝑓 0.34 ( 10427 hom., cov: 31)
Exomes 𝑓: 0.43 ( 136666 hom. )

Consequence

LDLR
NM_000527.5 synonymous

Scores

3

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:23

Conservation

PhyloP100: -4.22

Publications

1 publications found
Variant links:
Genes affected
LDLR (HGNC:6547): (low density lipoprotein receptor) The low density lipoprotein receptor (LDLR) gene family consists of cell surface proteins involved in receptor-mediated endocytosis of specific ligands. The encoded protein is normally bound at the cell membrane, where it binds low density lipoprotein/cholesterol and is taken into the cell. Lysosomes release the cholesterol, which is made available for repression of microsomal enzyme 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase, the rate-limiting step in cholesterol synthesis. At the same time, a reciprocal stimulation of cholesterol ester synthesis takes place. Mutations in this gene cause the autosomal dominant disorder, familial hypercholesterolemia. Alternate splicing results in multiple transcript variants.[provided by RefSeq, May 2022]
LDLR Gene-Disease associations (from GenCC):
  • hypercholesterolemia, familial, 1
    Inheritance: SD, AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Genomics England PanelApp, Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), Natera
  • homozygous familial hypercholesterolemia
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_000527.5, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACGS-UK Somatic Oncogenicity v2025

Classification was made for transcript:

Our verdict: Benign. The variant received -8 points.

B1High frequency in general population
GnomAD effective popmax AF >1% — B1 stand-alone benign; GnomAD effective popmax AF = 0.446 — exceeds 1% threshold (B1 applied)
B4Synonymous/intronic, no splicing impact
Synonymous/intronic variant with confirmed no splicing impact (B4 strong); Synonymous variant — splicing algorithms confirm no impact on splicing (B4 strong [-4])

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_000527.5. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

LDLR NM_000527.5
MANE Select
HGVSc / HGVSpc.1773C>Tp.Asn591Asn
Exon rankExon 12 of 18
synonymous
Prot: NP_000518.1UniProt: P01130-1
LDLR NM_001195798.2
HGVSc / HGVSpc.1773C>Tp.Asn591Asn
Exon rankExon 12 of 18
synonymous
Prot: NP_001182727.1UniProt: P01130-5
LDLR NM_001195799.2
HGVSc / HGVSpc.1650C>Tp.Asn550Asn
Exon rankExon 11 of 17
synonymous
Prot: NP_001182728.1UniProt: P01130-4

Ensembl Transcripts

LDLR ENST00000558518.6
TSL:1MANE Select
HGVSc / HGVSpc.1773C>Tp.Asn591Asn
Exon rankExon 12 of 18
synonymous
Prot: ENSP00000454071.1UniProt: P01130-1
LDLR ENST00000252444.10
TSL:1
HGVSc / HGVSpc.2031C>Tp.Asn677Asn
Exon rankExon 12 of 18
synonymous
Prot: ENSP00000252444.6UniProt: J3KMZ9
LDLR ENST00000558013.5
TSL:1
HGVSc / HGVSpc.1773C>Tp.Asn591Asn
Exon rankExon 12 of 18
synonymous
Prot: ENSP00000453346.1UniProt: P01130-5

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)
Rare (AF ≤ 0.0001 / Hom ≤ 1)
Global population databases 6 sources
GnomAD3 genomes
AF: 0.337
AC:51230
Hom:10439
AN:151818
Cov:31
GnomAD2 exomes
AF: 0.389
AC:97866
AN:251472
GnomAD4 exome
AF: 0.426
AC:622001
Hom:136666
AN:1461646
Cov:43
GnomAD4 genome
AF: 0.337
AC:51210
Hom:10427
AN:151938
Cov:31
TOPMed (Bravo)
AF: 0.321
AC:84921
Hom:16478
AN:264690
ALFA (dbGaP/dbSNP Allele Frequency Aggregator)
AF: 0.400
AC:182117
Hom:38700
AN:455066
Local & regional cohorts 11 sources
ABraOM SABE-WGS-1171
AF: 0.355
AC:832
Hom:162
AN:2342
ChinaMAP Phase 1
AF: 0.167
Denmark Genome
AF: 0.420
AC:126
AN:300
ESP6500 (Exome Variant Server)
AF: 0.335
AC:4360
AN:13006
GenomeAsia100K
AF: 0.266
AC:923
AN:3478
Korea4K (4,157 Koreans)
AF: 0.144
AC:1040
AN:7232
Qatari Genome
AF: 0.481
AC:965
AN:2008
ToMMo 61KJPN (+60KJPN MNV)
AF: 0.121
AC:14833
Hom:951
AN:122156
Turkish Variome
AF: 0.407
AC:2735
Hom:591
AN:6718
UK10K
AF: 0.449
AC:3392
AN:7562
WBBC (Westlake BioBank for Chinese) pilot
AF: 0.170
AC:1524
Hom:133
AN:8960
Showing 17 sources

Case/control cohorts

CohortCasesControls
AFACANAFACAN
ASC
(Autism)
0.414 *459211098 0.411 *724417604
BipEx
(Bipolar disorder (including schizoaffective))
0.438 1244728420 0.438 1263528844
Epi25
(Epilepsy)
0.389 1633041956 0.406 2712166882
SCHEMA
(Schizophrenia)
0.312 41202131958 0.329 69948212874
Showing 4 cohortsAllele count / allele number. AF is computed from the counts for ASC (not provided by the source).

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
9
Hypercholesterolemia, familial, 1 (9)
-
-
7
not specified (7)
-
-
4
Familial hypercholesterolemia (4)
-
-
2
not provided (2)
-
-
1
Cardiovascular phenotype (1)

Computational Scores

AlphaGenome AVI
Benign0.00076
BayesDel_noAF
Benign-0.74
CADD
Benign0.092
DANN
Benign0.70
GPN-Star LLR
N/A-0.71
GPN-Star score
N/A0.45
Mutation Taster
N/A98/2polymorphism (auto)
PhyloP100
Benign-4.2
RBP_binding_hub_radar
N/A0.0
RBP_regulation_power_radar
N/A1.7
Showing 10 of 10 scores

Splicing Scores

Pangolin (max)
Benign0.0
SpliceAI score (max)
Benign0.0
Details are displayed if max score is > 0.2
Showing 2 of 2 scores

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

MaveDB functional evidence

MaveDB is a public repository of laboratory assays that test the effect of thousands of variants at once — treat this as supporting research data and interpret it with great caution; it is not a clinical classification.

No MaveDB functional evidence found for this variant.

Publications

Other links and lift over

dbSNP: rs688;
hg19: chr19-11227602;
COSMIC: COSV52942945;
COSMIC: COSV52942945;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.